Free Trial
LON:CREO

Creo Medical Group (CREO) Share Price, News & Analysis

Creo Medical Group logo
GBX 12.88 +0.50 (+4.04%)
As of 07/11/2025 12:23 PM Eastern

About Creo Medical Group Stock (LON:CREO)

Key Stats

Today's Range
12.25
13
50-Day Range
9.80
16.13
52-Week Range
9.22
37
Volume
995,290 shs
Average Volume
1.27 million shs
Market Capitalization
£52.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CREO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter.

CREO Stock News Headlines

Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
Creo Medical Updates Shareholder Notification
See More Headlines

CREO Stock Analysis - Frequently Asked Questions

Creo Medical Group's stock was trading at GBX 20.40 on January 1st, 2025. Since then, CREO stock has decreased by 36.9% and is now trading at GBX 12.88.

Creo Medical Group PLC (LON:CREO) issued its quarterly earnings data on Monday, May, 19th. The company reported ($8.00) earnings per share for the quarter. Creo Medical Group had a negative net margin of 73.93% and a negative trailing twelve-month return on equity of 41.79%.

Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Creo Medical Group investors own include Aviva (AV), IQE (IQE), Lloyds Banking Group (LLOY), Barclays (BARC), BP (BP), BT Group (BT.A) and Coats Group (COA).

Company Calendar

Last Earnings
5/19/2025
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:CREO
CIK
N/A
Fax
N/A
Employees
279
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (6.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£25.04 million
Net Margins
-73.93%
Pretax Margin
N/A
Return on Equity
-41.79%
Return on Assets
-20.09%

Debt

Debt-to-Equity Ratio
29.96
Current Ratio
3.24
Quick Ratio
2.19

Sales & Book Value

Annual Sales
£33.87 million
Price / Sales
1.54
Cash Flow
GBX 5.30 per share
Price / Cash Flow
2.43
Book Value
GBX 13.11 per share
Price / Book
0.98

Miscellaneous

Outstanding Shares
404,265,846
Free Float
N/A
Market Cap
£52.05 million
Optionable
Not Optionable
Beta
0.86
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (LON:CREO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners